Following a transient period of ischemia, there is an initial hyperemia followed by a gradual decline to below normal levels referred to as "delayed hy poperfusion" (Sundt and Waltz. 1971; Rehncrona et aI. , 1979; Olsen and Larsen, 1981; Hossmann, 1982; Siesjo, 1984) . During and following the period of cerebral ischemia, there are several indexes indi cating a clear derangement of cerebral and cerebro vascular function. There is an immediate flattening of the EEG and a loss in amplitude and increase in latency of evoked potentials (Sharbrough et aI. , 1973; Tr ojaborg and Boysen, 1973; Branston et aI. , 1974 Branston et aI. , , 1979 Heiss et aI. , 1976; Astrup et aI., 1977; Siesjo, 1984) . During the reflow phase, EEG and (72 ± 9 ml/ IOO g/min). The CBF-PaC02 response dis played an approximately sevenfold reduction in slope at 2 h after retlow in saline-treated animals. This decrease in PaC02 reactivity was not observed in the ZS-pretreated animals. With regard to EEG, all animals showed a total flattening during the 15 min of ischemia. In saline-treated animals only one of seven showed any sign of even mar ginal recovery. In ZS-treated animals EEG activity showed prominent recovery in seven of seven. Brainstem auditory evoked potentials were monitored and showed prominent recovery of amplitude and latency in ZS but not saline-treated animals during reflow. Key Words: Ce rebral blood flow-C02 responsiveness-Cyclooxy genase inhibition-Reflow-Zomepirac sodium. evoked potentials display a delayed and incomplete return to normal (Trojaborg and Boysen, 1973; Branston et aI. , 1974; Siesjo, 1984) . Examination of cerebrovascular function has shown a loss of CO2 reactivity (Takagi et aI. , 1977; Kagstrom et aI. , 1983a; Okabe et aI. , 1983) and a reduction in the ability to respond to changes in MABP, e. g. , pres sure autoregulation (Takagi et aI. , 1977; Okabe et aI. , 1983 ).
An important question is the mechanism under lying the alterations in CBF following the initial ischemic event. Though complex, one class of agents thought to play a role in this phenomenon are the prostanoids (Moskowitz and Coughlin, 1981; Pickard, 1981; Crockard et al. , 1982; Shohami et aI. , 1982; Siesjo and Nilsson. 1982; Siesjo, 1984) . It is important to note that during the period of ischemia, there is a significant increase in free fatty acids (Kuwashima et aI. , 1976 (Kuwashima et aI. , , 1978 Gaudet and Levine, 1979; Gaudet et aI. , 1980; Rehncrona et aI. , 1982) , and this increase appears to be constituted largely by the 20: 4 carbon form, arachidonic acid (Gaudet et aI. , 1980; Yoshida et aI. , 1980; Rehn-crona et a\., 1982; Black et a\., 1984; Siesjo, 1984) . Arachidonic acid represents the essential precursor that, when acted upon by membrane-bound cy c\ooxygenase, gives rise to prostaglandins (PGs), a family of agents with diverse and potent biological effects Moskowitz and Coughlin, 1981; Crockard et aI., 1982; Moncada, 1983; Siesjo and Wieloch, 1983) .
Studies attempting to decipher the role of PGs in cerebral ischemia have made use of inhibitors of PG biosynthesis, principally, indomethacin. Though controversial, a number of studies have re ported enhanced cerebral reperfusion and cerebral protection (Furlow and Hallenbeck, 1978; McCul loch et a\., 1982; Kagstrom et a\., 1983h; Okabe et aI., 1983; Shigeno et aI., 1985) , though recovery of functional aspects of cerebrovascular regulation (such as PaC02 reactivity) has not been described.
Characterization of the role of PG inhibition re quires, first, the use of different cyc\ooxygenase in hibitors and, second, verification that the treatment regimen employed indeed produces an inhibition of cyc\ooxygenase activity in brain. The present study sought to further examine the role of cyclooxy genase activity using zomepirac sodium (ZS) on ce rebral reflow, CO2 responsivity, and functional ac tivity as defined as EEG and evoked potentials fol lowing a IS-min period of complete global cerebral ischemia in the cat. Zomepirac, which powerfully inhibits platelet aggregation (Pruss et aI., 1980) and is chemically related to tolmetin, is a cyclooxy genase synthesis inhibitor. The kinetics of ZS are such that high brain levels have been observed shortly after administration and prominent reduc tions in CSF PGs are observed within 30 min of ad ministration and this suppression continued in ex cess of 6 h (Romero et a\., 1981) .
METHODS

General preparation
Twenty-eight cats of either sex weighing 3-5 kg were fasted 12-18 h prior to experimentation, with free access to water. After induction of anesthesia with 4% halothane and O2, a tracheal tube was inserted and the surgical preparation carried out under 1.5-2.0% halothane. Halo thane (1 %) delivered in an 02/air/C02 mixture (1.0:5.0:0.02) was used for maintenance during the re mainder of the experiment. Pancuronium bromide (0.15 mg i. v.) was used to achieve initial muscle paralysis, fol lowed by smaller periodic doses as needed to maintain muscle paralysis after the animal was placed on a Har vard respirator. The right femoral artery and vein were cannulated to monitor blood pressure, obtain sequential samples for blood gases, and administer drugs. The left femoral artery was additionally catheterized in 14 animals that underwent complete global cerebral ischemia to J eerch Blood Flow Me/ab. Vol. 6, No.6, 1986 permit the withdrawal and injection of blood while moni toring the MABP. Arterial blood gases and pH were mea sured with a Radiometer blood gas analyzer, and hemato crit was assessed for each blood sample. Rectal tempera tures were monitored and the animals were maintained at normothermia by use of an underbody heating blanket.
To permit the rapid induction of a reversible complete cerebral ischemia. the thyrocervical. internal thoracic. and vertebral arteries were identified via a transaxillary approach with use of an Olympus operating microscope and occluded bilaterally with a bipolar cautery. This elim inated all blood flow to the head except that from the carotid arteries and the small amount supplied by the spinal arterial cascade (Hossmann et aI., 1976) . The ca rotid arteries were then exposed, with care taken to avoid distortion of the adjacent vagal nerve; silk ligatures were loosely placed around each artery. The surgical proce dure required �75 min to perform.
CBF measurement
To measure CBF. J33Xe was administered through a polyethylene (PE-50) catheter placed into the right lingual artery such that the tip of the catheter was at the bifurca tion of the lingual and carotid arteries. After the head of the cat was secured in a stereotaxic head holder, the skin. subcutaneous tissue. and temporalis muscle were re flected to expose the right temporoparietal portion of the skull. An external scintillation probe was positioned over this area. The calibration. collimation, and isoresponse curve of this detection used in this laboratory have been described previously (Cillufo et aI., 1981) . CBF was mea sured by monitoring the clearance of a 0.1 to 0.2-ml bolus of normal saline containing 200 j.-LCi of 133Xe injected into the right lingual artery. CBF was then calculated via the J33Xe washout curve using the I-min initial slope index method. a modification of the 2-min flow index method of Hutten and Brock (1969) .
EEG
To monitor EEG activity. five parasagittal I-mm drill holes were made bilaterally along with a vertex skull hole. Te n gold-plated pins were placed in these holes by which 10-channel EEG monitoring was carried out with a Grass model 6 electroencephalograph (see inset in Fig.  I ). EEG recordings were graded before, during, and after ischemia on a scale of 1-6 as described in Fig. 1 . Scoring was performed without knowledge of drug treatment.
In four of the animals undergoing reversible complete global ischemia (two drug treated and two untreated), brainstem auditory evoked responses (BAE R) and an on line computer power and frequency analysis of EEG ac tivity were carried out using a Neurotrac microprocessor (Interspec. Inc .. Conshohocken, PA, U.S.A.). Methods for such monitoring have been previously described else where (Bickford et al.. 1972; Chiappa, 1983) .
CSF was removed from the cisterna magna of each cat at the end of each experiment immediately prior to death for measurement of prostanoid levels. PGE2, PGF2" , 6keto-PGF)" (the stable metabolite of PGI2, prostacyclin), and thromboxane (Tx) B2 were extracted, concentrated, and measured via radioimmunoassay as previously de scribed (Romero et aI., 1984) . The absolute sensitivity of each of the assays was 3-4. 2.5-5, and 1.5-3 pg/ml of CSF, respectively. 
Experimental design
The typical experimental sequence consisted of sur gical preparation (�75 min) and the injection of drug (or saline), assessment of preischemia CBF -PaC02 response function, initiation of ischemia for 15 min. reflow for 2 h. assessment of postischemia CBF-PaC02 response func tion, removal of CSF from cisterna magna, and then death of the animal.
Four groups of seven cats each were used to evaluate the changes in CBF, CBF -P aC02 responsiveness, and EE G recovery after a IS-min period of reversible com plete global ischemia. Groups 1 and 2 were nonischemic saline-and ZS-treated controls, respectively. These two groups were used to evaluate the changes in CBF, CBF PaC02 responsiveness, and EEG over a ISO-min period under halothane anesthesia, in which no ischemic insult was inflicted. Groups 3 and 4 were subjected to a IS-min period of reversible complete global ischemia and 2 h of reflow as described above. Again the same parameters were evaluated. and again one group was untreated (group 3) and the other received ZS (group 4). Animals receiving ZS pretreatment were given ZS (5 mg/kg i.v.) I h prior to completion of surgical preparation and initia tion of the first CBF -PaC02 response sequence.
Reversible complete cerebral ischemia was achieved by lowering the MABP of the animals to �80 mm Hg by the withdrawal of arterial blood via a heparinized syringe and occluding the carotid arteries with aneurysm clips placed on each. The jaws of these clips had sufficient pressure to eliminate blood flow through the carotid ar tery without visibly damaging it when removed. Exami nation of the EEG revealed no change during the brief interval of hypotension prior to occlusion. but a complete loss of activity within 10-15 s of the placement of the aneurysm clips. The completeness of the ischemia was monitored by injecting 133Xe via the right lingual artery catheter just prior to the clipping of the carotid arteries. Ischemia was considered complete only when 133Xe ac tivity levels did not decrease by > 10% during the IS-min occlusion interval (Hossmann et aI., 1976) . In general the washout curve generated during the 15 min had an effec tive slope of zero with little detectable washout until ca rotid flow was reestablished. Reflow was established by reinfusion of blood through the right femoral vein cath-eter -30 s before the end of the IS-min ischemic period and removal of the aneurysm clips from the carotid ar teries.
To assess the functional response of the cerebral vascu lature, the CBF response to changes in Peo2 was carried out by examining I33Xe washout under a sequence of nor mocarbia, hypocarbia, and hypercarbia with nominal PaC02 values of 40, 20, and 60 mm Hg, respectively. In each case PaC02 was adjusted by changing the concen tration of CO2 in the inspired gas and ventilatory rate for 10-15 min before I33Xe injection. In each case arterial blood gases were determined immediately before the CBF measurement.
Statistics
Data are presented as means ± SE or as percentage change from baseline. The best-fit line for each of the CO2 responses measured for each animal was determined using a least-squares linear regression. Comparisons be fore and after treatment were carried out using a one-way repeated-measures analysis of variance. Comparisons be tween scored data (such as EEG grades) were carried out using a Wilcoxon rank summary test.
RESULTS
Control
In the halothane-anesthetized control animals re ceiving either saline or ZS (5 mg/kg i. v. ), over the 150-min interval, baseline physiological parameters remained within normal limits (Table 1) . CBF as de fined by xenon clearance was initially 115 ± 15 and 92 ± II mlllOO g/min for the saline-and ZS-treated animals, respectively. These values did not differ statistically at any time (p > 0. 10). As shown in Fig. 2 , after the initial 30-min interval, the normo carbic flow for both groups fell gradually to � 70 mlllOO g/min, where it remained for the rest of the experiment. This initial decline is consistent with that in previous reports with halothane (Smith et aI. , 1970; Miletich et aI. , 1976; Boarini et aI. , 1983) and was not associated with any changes in blood gases or MABP (see Ta ble 1) or accompanied by any drastic change in CO2 responsiveness ( Fig. 3 ) or EEG.
CBF covaried significantly with increased PaC02. The graph on the left in Fig. 3 presents the CBF-PaC02 response in nonischemic saline-and ZS-treated cats measured at 0-30 and at 120-150 min after initiation of the flow studies. As indicated in both Fig. 3 and Ta ble 3, the slopes for all groups of animals determined in the beginning of the ex periment did not differ significantly (p > 0. 20). Figure 3 also demonstrates that although there was some change in slope and a shift of the curve to the right, CBF for the control animals still covaried with changes in PC02.
EEG activity, monitored continuously through out the experiment in control and ZS-treated an imals, was graded as defined in Fig. 1 . All non ischemic saline-and drug-treated cats displayed an EEG grade of 0 or 1 for the duration of these exper iments. As indicated, these animals routinely dis played EEG activity characterized by low to mod erate amplitude with fast activity.
Postocclusion
Immediately following hypotension and carotid occlusion, the clearance of the cerebral 1 33Xe was essentially zero. As shown in the typical flow pat terns presented in Figs. 4 and 5, during the interval of the occlusion, there was a <5% decline in 1 33Xe clearance, suggesting complete ischemia. Immedi ately following reestablishment of perfusion, CBF in untreated animals displayed hyperemia with flows averaging 141 ± 9 mlllOO g/min at �5-15 min postocclusion. This period of hyperperfusion lasted for �40 min and then showed a clear decline below normal for the remainder of the experiment, with the CBF values after 120 min of reflow being 26 ± 1 60 3 ml/100 g/min in untreated animals (Fig. 6 ). This value is statistically less than those for both preoc elusion control (p < 0.05) and saline-treated non ischemic controls measured at comparable times (p < 0. 01) (see Figs. 2 and 6). This hypoperfusion phase was not accompanied in the postreflow in tervals by any significant alteration in baseline blood gases or physiological measures ( Table 2) .
As indicated in Fig. 3 and Ta ble 3, there were no differences between the slope of the first CBF PaC02 response curves for the four treatment groups. Examination of the second CBF-PaC02 re sponse curves determined 2 h following 15 min of complete cerebral ischemia revealed a prominent reduction in the slope of the untreated cats (group 3), which was statistically significant as compared with both the preocclusion slope of the same group and the slope of the nonoccluded group determined at a comparable time ( tion in the CO2 response is graphically demon strated in the typical xenon clearance curves from the experiment presented in Fig. 4 . As the MABP and blood gas values in the postischemic interval were comparable with the values observed in the preischemia CO2 response examination as well as with those in control animals, it is not likely that the failure to see an elevation in flow during hyper carbia was due to a change of arterial pressure (Table 2) or to halothane anesthesia (Fig. 3) .
Concomitantly with the loss of blood flow, the EEG showed a severe suppression to Grade 6 within 10-15 s (see Fig. 1 ). As summarized in Fig.  1 , EEG profiles of Grades 0-1 were typically seen in both groups of cats prior to ischemia. During the reflow interval, untreated animals showed little EEG evidence of recovery. As shown in Fig. 7 , only one untreated animal of seven showed any major improvement in EEG grade at the 120-min postocclusion examination (p < 0.01; Wilcoxon matched sample).
Treatment of animals with ZS had no significant effect on the initial magnitude of CBF observed during the immediate postreflow interval (Fig. 6) . However, during the delayed hypoperfusion phase, there was a statistically significant elevation in CBF as compared with non-ZS-treated animals. Thus, at the end of the 2-h reflow interval, CBF at normocarbia in the ZS-treated cats was 72 ± 9 ml/100 g/min. This difference was observed as early as 60 min after reflow and remained for the duration of the experiment (Fig. 6) . ZS-treated animals (group 4) did not differ statistically from either sa- line-or ZS-treated controls examined at compa rable time intervals (p > 0. 10). Examination of the PaC02 response curve re vealed that ZS treatment served to preserve the functional response characteristics of the cerebro vascular system to changes in arterial PaC02 after ischemia. In Fig. 5 postocclusion washout curves for a ZS-treated cat display the characteristic re sponse to changes in PaC02. This reactivity is in contrast to the lack of response observed in the post occlusion flows of non-ZS-treated animals (Fig. 4) . As shown in Fig. 3 , the slope of the PaC02 response curve measured in the ZS-treated animals after 120 min of reflow did not differ from that of any of the nonischemia control animals. This is in contrast to the significant reduction in slope ob served in animals not receiving ZS treatment (group 3) ( Fig. 3; Ta ble 3) .
In addition to the effects on CB F, examination of the action of ZS on the EEG revealed a striking protective effect. Thus, as indicated in Fig. 7 , ZS treated cats displayed recovery of EEG activity to grades remarkably comparable with the preocclu sion profiles. This is in marked contrast to the poor recovery of EEG observed in the non-drug-treated ischemic animals (see Fig. 7 ). In this series all ZS treated animals showed a striking return to pre ischemia EEG profiles. Based on the Wilcoxon rank sum test analysis, the difference between sa line-(group 3) and ZS-(group 4) treated groups was statistically significant (p < 0. 01).
The above effects of ischemia on EEG grade and the effects of ZS were corroborated in the limited number of animals (two saline and two ZS treated) where an on-line computer power and frequency spectral analysis and BAERs were examined. Figure 8 presents records before and after ischemia and illustrates the continued failure of EEG activity after 120 min in saline-treated animals and the prominent effects produced by ZS on EEG activity. Examination of the corresponding BAERs in these same animals (as indicated in Fig. 9 ) also revealed a protective effect of ZS treatment on the magnitude of the BAER waves 1-5, though in all animals, ZS or saline treated, the increased latency of wave 5 remained increased by 15-20%. Figure 10 displays the log plot of the levels of PGs measured in crystal-clear cisternal CSF imme diately prior to death. Levels of 6-keto-PGFj<x, TxB2, PGF2<x, and PGE2 were measured in normal cat CSF with the relative order of levels being 6keto-PGFj<x > TxB2 > PGF2<x = PGE2 (p < 0.05) (one-way analysis of variance/Newman KeuIs). The Values are means ± SE. Control animals (n = 7). Treated animals (n = 7) given zomepirac sodium (5 mg/kg i. v.) 1.75 h prior to time O. Halothane concentration 1.0%. Time 0 is started at the initiation of retlow after the IS-min ischemic period. Time period -45 to -15 min is the first PaC02 response maneuver done prior to induction of 15 min of complete fo rebrain ischemia. Time period 90 to 120 min is the second PaC02 response maneuver started after 15 min of complete fo rebrain ischemia. Maneuver started after �90 min of retlow. All animals were subjected to a IS-min period of complete global ischemia.
CSF PGs
ratio of levels was I :0.4:0.2:0.2. Two hours after the IS-min ischemic episode in saline-treated cats (group 3), significant increases in the levels of CSF prostanoids as compared with control were noted (PGE2: 2. I-fold = 6-keto-PGF 1 a: 2. 7-fold > TxB2: 16-fold > PGF2a: 44-fold) (p < 0. 05). The ratio of prostanoid levels in ischemic saline-treated animals was 1:2.3:3.9:0.3 (for 6-keto-PGF 1 a, TxB2, PGE2a, and PGE2, respectively), indicating an apparent preferential increase in the relative levels of TxB2 and PGF2a. ZS treatment significantly diminished the levels of cisternal PGs in both the ischemic and the non ischemic animals. The ratio of prostanoid activity in nonischemic ZS-treated animals was 1:0.3:0.3:0.1. After ZS treatment the ratio of levels in ischemic animals was 1 :0.9:0.4:0.1. In ischemic animals the reduction produced by ZS (group 4) as a percentage of the corresponding saline-treated animals (group 3) was 6-keto-PGF1a, 76%; TxB2, 87%; PGF2a, 97%; and PGEz, 91%. These reductions by Zomax were statistically significant (p < 0.05; analysis of variance).
DISCUSSION
Sequelae of transient ischemia
An initial hyperemia and delayed hypoperfusion are well-documented CBF patterns seen following a discrete period of global complete or incomplete cerebral ischemia in a variety of species, including both cats and humans (Sundt and Waltz, 1971; Rehncrona et aI. , 1979; Olsen and Larsen, 1981; Kagstrom et al. , 1983a; Siesjo, 1984) . During and following such an ischemic event, there is a loss of the cerebrovascular response to P aC02 (Pickard and MacKenzie, 1973; Kagstrom et al. , 1983a) and impairment of cerebral activity as indicated by a flattening and slowing of the EEG and a loss of the auditory evoked potentials (Chiappa, 1983) . The mechanisms underlying these profound effects are a subject of considerable interest.
The reduction in available metabolic substrates results in a complex series of events leading to the failure of cell function. These include the loss of transmembrane ionic homeostasis (see Siesjo, 1981) and an increase in the levels of intracellular Values are means ± SE. Zomepirac sodium (PS) (5 mg/kg i.v.) given 1 h prior to first flow. Group I and 2 animals were cats in which no ischemia was performed. Group I animals were un treated. whereas group 2 animals received zomepirac sodium. Group 3 and 4 animals were cats that were subjected to a 15-min period of complete global ischemia. Group 3 animals were un treated, whereas group 4 animals were pretreated with zome pirac sodium. a Slope, fl, ± 95% CI (mIIIOO g/min/mm Hg).
h The first CO2 response curve was determined at 0-30 min (prior to ligation in ischemic cats). The second CO2-CBF re sponse curve was determined at 120 min after time 0 (time of occlusion in ischemic cats, groups 3 and 4).
Ca
2 + secondary to Cao influx (as the neuronal membrane depolarizes) (Harris et aI. , 1981) and from intracellular stores (such as mitochondria) (Godfraind et aI. , 1971) . Free fatty acids, particu larly arachidonic acid, will accumulate in brain during ischemia, and elevated levels will persist during the reperfusion phase (Rehncrona et aI. , 1982) . Though free fatty acids can have direct dele terious effects on cell function (e. g. , resulting in potential changes in the physicochemical properties of the membrane secondary to their detergent prop erties, uncoupling of oxidative phosphorylation) (see Wieloch and Siesjb, 1981) , their conversion in the presence of oxygen by membrane-bound cy clooxygenase and lipoxygenases gives rise to agents that have direct pharmacological effects on vascular function (Hallenbeck and Furlow, 1979; Moskowitz and Coughlin, 1981; Okabe et aI. , 1983) and that, in the course of their formation, give rise to highly reactive superoxide intermediaries (Kontos, 1985) , which by virtue of their free radical character can lead to significant damage of mem brane components. Measurement of the extracel lular levels of a variety of cyclooxygenase products in cat ventricular perfusates has shown highly sig nificant increases occurring immediately after the onset of ischemia and remaining prominently ele vated during the ensuing 2 h of reflow (M. K. Stevens, T. L. Yaksh, and S. D. Romero, unpub lished observations) . In view of the prominent ef fects of the concurrent generation of these cycloox ygenase products and their potent effects on vas cular systems, the present study was directed at assessing the role of these cyclooxygenase-gener ated products on cortical electrical and vascular function.
Effects of ZS on CNS PG synthesis
ZS, as demonstrated in these experiments, is a potent and rapidly acting inhibitor of cyclooxy genase activity in the CNS of cats when given peri pherally. Thus, a highly significant reduction in CSF PGE2 was observed within 30-60 min of ad ministration (Romero et aI. , 1981) . CSF samples taken at the end of these experiments (Fig. 10 ) and other studies (Romero et aI. , 1981) indicate this ef fect of ZS on cyclooxygenase products and verify that the present paradigm of drug treatment did in deed suppress cyclooxygenase activity during the time frame of these experiments.
Cerebrovascular effects
In the present study ZS treatment had no signifi cant effect on the magnitude or duration of the ini- tial hyperemic phase, In contrast, the hypoperfu sion phase during the reflow period was consider ably attenuated and the failure of the CBF-PaC02 coupling was prevented in ZS-treated cats. Impor tantly, ZS in control animals (a) had no significant effect on resting flow, (b) did not alter the slope of the control CBF -C02 response function, and (c) had no effect on MABP in the normal or ischemic cats. These observations suggest that the flow-pro moting effects of ZS were not due to a general alter ation in the resistance of the vascular tree or an in crease on perfusion pressure.
Several speculative mechanisms may be consid ered whereby prostanoid inhibition might preserve cortical perfusion in the postreflow phase. First, the greatest inhibition was seen in TxB2 and PGE2, both of which are known to cause vasoconstriction and, in the case of TxB2, platelet aggregation (Mos kowitz and Coughlin, 1981; Moncada, 1983) , A re duction in the presence of these prostanoids would intuitively result in less cerebral damage and im proved blood flow, thereby enhancing tissue perfu sion. Surprisingly, the least inhibition was seen in 6-keto-PGF 1 o:. 6-Keto-PGF 1 o: is the stable metabo- lite of prostacyclin, PGI2, which is reported to in hibit platelet aggregation, produce vasodilation. and stabilize the cellular membrane (Hallenbeck and Furlow, 1979; Moncada et al. . 1980; Moskowitz and Coughlin, 1981; Gryglewski et al. . 1983; Mon cada, 1983) . Such effects would likely benefit tissue perfusion directly. Thus. the positive effects of ZS on cerebral perfusion following a discrete period of cerebral ischemia may be through inhibition of va soconstrictive prostanoids (such as PGE2. PGF2a. and TxB2) and by its relative sparing of prostacy clin synthesis. The mechanism for such relatively selective effects is not known. Second, as noted above, cyclooxygenase activity leading to prostanoid synthesis is associated with the generation of transient reactive molecular species such as 02' Inhibition of this synthesis cycle should predictably lead to a reduction in such species. Free radical generation has been hypothe sized to play a significant role in endothelial damage and subsequent effects on vascular reac tivity (Kagstrom et aI. , 1983a; Black et aI. , 1984; Siesjo, 1984; see Kontos, 1985) . With regard to CO2 reactivity. previous reports have suggested a possible increase in capillary per meability and in intracranial pressure. Such changes have been evoked by several PGs. in cluding TxB. PGE2, and PGF2a, as well as various free radicals. Thus, the elevated intracranial pres sure could serve in part to diminish both resting flow and cardiovascular reactivity (Black et aI. , 1984) . Alternatively. we would offer the speculative hypothesis that the reappearance of the CO2 re sponse function is not related to a direct effect on the vessel, but may also reflect a failure of neuronal mechanisms that serve CBF-PaC02 coupling. For instance. in cats significant attenuation of the PaC02 response curve has been observed after brainstem lesions in the vicinity of the locus ce ruleus (Reddy et al. . 1986 ). The return of neuronal function as measured by the EEG and brainstem evoked potentials is consistent with such a hy pothesis.
An additional observation in the present experi ments is that in spite of verified inhibition of cy clooxygenase activity. there was no change in ei ther resting CBF or the CBF response to CO2, The lack of effect on CO2 responsiveness following ZS is in contrast to previous studies with indomethacin where a significant diminution in the slope of the CBF-PaC02 response was noted (McCulloch et aI. , 1982; Kagstrom et aI. , 1983b) . This is further evi dence suggesting that prostanoids play no role in normal cerebrovascular reactivity. particularly to changes in PaC02• Neural effects of PG inhibition ZS had no evident effect on EEG activity in con trol animals, but during reflow there was a promi nent recovery of EEG frequency and amplitude, while BAERs in the ZS-but not saline-treated cats displayed a return to near preischemia values.
The prominent return of cortical function fol lowing transient global cerebral ischemia occurs in parallel with the significant preservation of CBF during the later reflow phase. These results are consistent with speculations that improving the flow during the "delayed hypoperfusion phase" of reflow is beneficial in cerebral recovery from an ischemic event (Sharbrough et aI. , 1973; Levy and Duffy, 1977; Hallenbeck and Furlow, 1979; Nemoto et aI. , 1981; Hossmann, 1982; Kagstrom et aI. , 1983b; Moncada, 1983; Steen et aI. , 1983) . Directly stated, this conclusion suggests that after a tran sient ischemia, neural tissue has the ability to dis play a marked return of function, but this is limited by inadequate perfusion (Siesjo, 1981) . Alterna tively, several lines of evidence have indicated that there is a reduced metabolic requirement (Pulsinelli et aI. , 1982) , that the energy state of the brain at this time is not unfavorable (Welsh et aI. , 1978) , and that because of the low CMR02, brain oxygen ten sion is adequate to sustain function (Ingvar et aI. , 1960) . Thus, this raises the possibility that the ame liorating effects of PG synthesis inhibition on post ischemic deficit may reflect a direct consequence of PG synthesis on neuronal function. There is ample evidence indicating that PGs can exert a direct sup pressive effect on neuronal function. A variety of intracerebrally administered prostanoids have dis played significant anticonvulsant effects (Poddu biuk et aI. , 1977; Bhattacharya and Sanyal, 1978; Rosenkranz, 1978; Rosenkranz and Killam, 1981; Forstermann et aI. , 1982) . Significantly, PG syn thesis inhibition has been shown to lower convul sive thresholds (Steinhauer and Hertting, 1981) . Whether or not these effects reflect on the present actions of cyclooxygenase inhibition is not known, but the potent direct effect on neuronal function emphasizes mechanisms that may be independent of direct effects on cerebral perfusion. The mecha nism of the direct and acute effects on neuronal function is not known, but the comments made above regarding the formation of reactive elements and their direct effect on membrane function are relevant to this discussion.
In summary, these experiments suggest that inhi bition of a cyclooxygenase is beneficial in recovery from periods of cerebral ischemia. Though at the doses employed ZS exerts a potent suppressant ef fect on prostanoid synthesis, other undefined ef fects of the drug may also be relevant. Neverthe less, the comparable effects of several structurally diverse agents whose common effect is cyclooxy genase inhibition offer further support for a signifi cant but as-yet undefined role of these lipidic acids and/or the byproducts of their synthesis.
